Stephen B. Shrewsbury

1. STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD ® ) Device, in Healthy Adult Subjects
   2019/01/19 by Stephen B. Shrewsbury, Maria Jeleva, Kelsey Satterly +2 · 1 voice · 1 citation
   Medicine · Neuroscience · #Migraine and Headache Studies #Olfactory and Sensory Function Studies #Respiratory and Cough-Related Research
2. Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism
   2009/09/14 by Robert O. Cook, Stephen B. Shrewsbury, Nabih M. Ramadan · 1 citation
   Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics · #Neurotransmitter Receptor Influence on Behavior #Pharmacogenetics and Drug Metabolism #Pharmacology and Obesity Treatment